New Zealand markets closed

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
46.12+0.85 (+1.88%)
At close: 04:00PM EST
46.51 +0.39 (+0.85%)
Pre-market: 04:00AM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
12,567,000
11,888,000
9,913,000
10,735,000
9,823,000
Cost of revenue
3,962,000
3,760,000
3,510,000
3,181,000
2,883,000
Gross profit
8,605,000
8,128,000
6,403,000
7,554,000
6,940,000
Operating expenses
Research development
1,313,000
1,204,000
1,143,000
1,174,000
1,113,000
Selling general and administrative
4,510,000
4,359,000
3,787,000
3,941,000
3,569,000
Total operating expenses
6,619,000
6,304,000
5,719,000
5,814,000
5,281,000
Operating income or loss
1,986,000
1,824,000
684,000
1,740,000
1,659,000
Interest expense
493,000
341,000
361,000
473,000
241,000
Total other income/expenses net
-635,000
-412,000
-405,000
-612,000
-1,000
Income before tax
864,000
1,076,000
-79,000
687,000
1,422,000
Income tax expense
214,000
36,000
2,000
-4,013,000
-249,000
Income from continuing operations
653,000
1,041,000
-82,000
4,700,000
1,671,000
Net income
653,000
1,041,000
-82,000
4,700,000
1,671,000
Net income available to common shareholders
596,000
985,000
-115,000
4,700,000
1,671,000
Basic EPS
-
0.69
-0.12
3.38
1.21
Diluted EPS
-
0.69
-0.12
3.33
1.19
Basic average shares
-
1,422,300
1,416,700
1,391,500
1,381,000
Diluted average shares
-
1,433,800
1,416,700
1,410,600
1,401,400
EBITDA
-
2,510,000
1,405,000
2,171,000
2,557,000